@article{article, title  = {{Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications.}},

 url = {{}},

 year = {{1998}},

 month = {{4}},

 author = {{van Hout BA and Bowman L and Zelinger DJ and Simoons ML}},

 volume = {{19 Suppl D}},

 journal = {{Eur Heart J}},

 pages = {{D59-D66}},

 note = {{Accessed on 2024/10/22}}}